SG11201605757SA - Substituted amino triazoles, and methods using same - Google Patents

Substituted amino triazoles, and methods using same

Info

Publication number
SG11201605757SA
SG11201605757SA SG11201605757SA SG11201605757SA SG11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA SG 11201605757S A SG11201605757S A SG 11201605757SA
Authority
SG
Singapore
Prior art keywords
methods
same
substituted amino
amino triazoles
triazoles
Prior art date
Application number
SG11201605757SA
Other languages
English (en)
Inventor
Michael L Corman
William M Hungerford
Adam Golebiowski
Raymond P Beckett
Marzena Mazur
Sylwia Olejniczak
Jacek Olczak
Original Assignee
Inst Drug Discovery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Drug Discovery filed Critical Inst Drug Discovery
Publication of SG11201605757SA publication Critical patent/SG11201605757SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11201605757SA 2013-12-20 2014-12-19 Substituted amino triazoles, and methods using same SG11201605757SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919117P 2013-12-20 2013-12-20
PCT/US2014/071490 WO2015095701A1 (en) 2013-12-20 2014-12-19 Substituted amino triazoles, and methods using same

Publications (1)

Publication Number Publication Date
SG11201605757SA true SG11201605757SA (en) 2016-08-30

Family

ID=53403739

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201605757SA SG11201605757SA (en) 2013-12-20 2014-12-19 Substituted amino triazoles, and methods using same

Country Status (9)

Country Link
US (1) US10214531B2 (pl)
EP (1) EP3082805B1 (pl)
JP (1) JP2017501226A (pl)
CN (1) CN106659715A (pl)
AU (1) AU2014369053B2 (pl)
CA (1) CA2937147A1 (pl)
PL (1) PL3082805T3 (pl)
SG (1) SG11201605757SA (pl)
WO (1) WO2015095701A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6836502B2 (ja) * 2014-05-30 2021-03-03 スプハエラ ファーマ ピーヴィーティー リミテッド 抗結核薬としての新規な化合物
PL415073A1 (pl) * 2014-12-19 2016-06-20 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
US10273244B2 (en) 2015-08-05 2019-04-30 Indivior Uk Limited Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators
PL415078A1 (pl) * 2015-09-04 2017-03-13 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
US11440884B2 (en) * 2017-08-21 2022-09-13 Acadia Pharmaceuticals Inc. Compounds, salts thereof and methods for treatment of diseases
WO2019040107A1 (en) 2017-08-21 2019-02-28 Acadia Pharmaceuticals Inc. COMPOUNDS, CORRESPONDING SALTS AND METHODS FOR THE TREATMENT OF DISEASES
CR20240101A (es) 2018-03-08 2024-05-24 Incyte Corp COMPUESTOS DIÓLICOS DE AMINOPIRAZINA COMO INHIBIDORES DE PI3K-y (DIVISIONAL 2020-464)
CN108467395B (zh) * 2018-05-09 2020-12-11 大连理工大学 一种几丁质酶抑制剂及其应用
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
CN114450274A (zh) 2019-07-11 2022-05-06 伊斯凯普生物公司 作为lrrk2抑制剂的吲唑及氮杂吲唑
EP4041726A1 (en) * 2019-09-25 2022-08-17 Molecure SA Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine
CN111732571B (zh) * 2020-07-24 2021-06-29 广西壮族自治区农业科学院 一种用于防治香蕉枯萎病的杀植物真菌剂
CN114835687B (zh) * 2021-04-02 2023-09-05 北京华森英诺生物科技有限公司 AhR抑制剂
JP2024522192A (ja) 2021-06-14 2024-06-11 スコーピオン セラピューティクス インコーポレイテッド がんを処置するために使用され得る尿素誘導体
US20230348516A1 (en) * 2022-04-29 2023-11-02 Molecure S.A. Ykl-40 inhibitors and their therapeutic applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421753A (en) * 1982-01-15 1983-12-20 American Cyanamid Company 1-(5-Amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines
US4582833A (en) * 1984-04-16 1986-04-15 American Cyanamid Company 2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
GB0325745D0 (en) * 2003-11-05 2003-12-10 Astrazeneca Ab Chemical compounds
EP2308870A3 (en) * 2005-06-01 2011-10-19 UCB Pharma S.A. 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
WO2009082526A2 (en) * 2007-10-05 2009-07-02 Pharmacopeia, Inc. Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
MX2013010970A (es) * 2011-03-24 2013-10-17 Cellzome Ltd Novedosos derivados de triazolil piperazina y triazolil piperidina sustituidos como moduladores de gamma-secretasa.

Also Published As

Publication number Publication date
US20160297823A1 (en) 2016-10-13
AU2014369053B2 (en) 2019-03-14
PL3082805T3 (pl) 2020-09-21
EP3082805A1 (en) 2016-10-26
EP3082805A4 (en) 2017-05-10
WO2015095701A1 (en) 2015-06-25
CA2937147A1 (en) 2015-06-25
AU2014369053A1 (en) 2016-07-28
US10214531B2 (en) 2019-02-26
CN106659715A (zh) 2017-05-10
EP3082805B1 (en) 2020-02-05
JP2017501226A (ja) 2017-01-12

Similar Documents

Publication Publication Date Title
IL276106A (en) Garp-binding proteins and their uses
SG11201605757SA (en) Substituted amino triazoles, and methods using same
GB201319878D0 (en) Method, Array and use thereof
GB201306633D0 (en) Biaising circuitry and method thereof
HK1198908A1 (en) Beauty aid
IL240248A0 (en) Met-binding substances and their uses
EP3012292A4 (en) TREATMENT ADJUVANT, AND COMPOSITION
GB201312318D0 (en) Novel methods and compounds
IL239762A0 (en) Selective nox-1 blocking peptides and their use
GB201300376D0 (en) Method and compound
ZA201507580B (en) Urea mixtures and methods for making and using same
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
GB201308057D0 (en) Protein
GB201313803D0 (en) Fungicidal composition and method
SI3033532T1 (sl) Vezni element, uporaba in postopek
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201401955D0 (en) Protein
EP3015549A4 (en) NOVEL POLYPEPTIDE AND USE THEREOF
GB201301640D0 (en) Methods and peptides
GB201302030D0 (en) Protein
GB201302031D0 (en) Protein
GB201315289D0 (en) Compound and method
GB201315300D0 (en) Compound and Method
GB201315298D0 (en) Compound and method
GB201315296D0 (en) Compound and method